AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Oil’s plunge below already is forcing a rapid rethink of the Fed’s rate path as energy prices cool and inflation sign...
A growing cohort of high-earning workers is leveraging the Mega Backdoor Roth Strategy to build Roth balances inside ...
Cape Verde's Vozinha has surged to a $17 million valuation as World Cup spotlight boosts a small nation’s brand. Inve...
Bed Bath & Beyond reveals a three-pilot strategy to build a housing platform after purchasing Fathom Holdings. The pl...
Analysts warn that russia’s economy ‘sputtering,’ putin’s wartime spending model is under mounting pressure as sancti...
Ethereum tests a critical barrier near $1,800 as traders watch for a breakout that could unlock a rally toward $2,000...
A niche crypto startup unveils a plan to tokenize a barrel of crude on a blockchain, potentially widening access to o...
A wave of U.S. retirees is moving to Greece, living on roughly $2,800 a month as they navigate visas, healthcare, and...
June data from the National Association of Realtors shows pending home sales fall 5.4% month over month, reflecting a...
FTX launches a $900 million creditor payout on July 31 to eligible holders, while 45 jurisdictions remain blocked fro...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...